CNBC
We're increasing our Eli Lilly price target after another beat-and-raise quarter
The strength of its GLP-1 business suggests the stock still has more room to run.
Related stories
Buenos Aires Times
BusinessAug 5, 2026 · 1 min
Argentina renews US$19-billion China swap for another five years
Buenos Aires Times
TASS
BusinessAug 5, 2026 · 1 min
Trump administration refunds importers about $100 bln in previously collected tariffs
TASS
The Guardian
BusinessAug 5, 2026 · 1 min
Trump team pushes to block court order giving BBC access to financial records
The Guardian
Bloomberg
BusinessAug 5, 2026 · 1 min
MetLife’s Earnings Beat Wall Street Expectations
Bloomberg